Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

Alan Menter, Alice Gottlieb, Steven R. Feldman, Abby S. Van Voorhees, Craig L. Leonardi, Kenneth B Gordon, Mark Lebwohl, John Y.M. Koo, Craig A. Elmets, Neil J. Korman, Karl R. Beutner, Reva Bhushan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

996 Scopus citations

Abstract

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of the guidelines of care for psoriasis, we discuss the classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues. Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis.

Original languageEnglish (US)
Pages (from-to)826-850
Number of pages25
JournalJournal of the American Academy of Dermatology
Volume58
Issue number5
DOIs
StatePublished - May 2008

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics'. Together they form a unique fingerprint.

Cite this